Combination of a serotonin reuptake inhibitor with an antipsychotic for use in depression in compulsive obsessive pathology and in PSYCHOSIS

摘要

The present invention relates to a method of treating depression, obsessive compulsive disorder and psychosis in a mammal, including a human, by administering to the mammal an atypical antipsychotic in combination with an antidepressant agent with improvement in efficiency. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, an atypical antipsychotic, and an SRI.